Search Within

Geoffrey Yuyat Ku

Formats
  1. Meeting Abstract (105)
  2. Journal Article (104)
  3. Book Section (11)
  4. Review (8)
  5. Guidelines (2)
  6. Conference Paper (1)
  7. Correspondence (1)
  8. Editorial (1)
  9. Miscellaneous (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (235)
  2. Gastrointestinal Oncology Service (235)
  3. Hematologic Malignancies, Division of (235)
  4. Solid Tumor Oncology Division (235)
  5. Center for Pancreatic Cancer Research (102)
  6. Epidemiology and Biostatistics (96)

More Groups

People
  1. David Ilson (123)
  2. Yelena Janjigian (110)
  3. Marinela Capanu (55)
  4. David Kelsen (53)
  5. Steven Maron (51)
  6. Laura Tang (49)

More People

Years
  1. 2025 (12)
  2. 2024 (19)
  3. 2023 (20)
  4. 2022 (19)
  5. 2021 (23)
  6. 2020 (18)

More Years

Publications
  1. Journal of Clinical Oncology (75)
  2. Annals of Oncology (20)
  3. Annals of Surgical Oncology (10)
  4. Clinical Cancer Research (10)
  5. International Journal of Radiation Oncology, Biology, Physics (7)
  6. Annals of Surgery (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (75)
  2. Oxford University Press (24)
  3. Elsevier Inc. (23)
  4. Springer (21)
  5. American Association for Cancer Research (14)
  6. Lippincott Williams & Wilkins (10)

More Publishers

Results (235)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor mutation burden (TMB) and immune- related adverse events (irAEs) compared to antibiotic (abx) use to predict for response to immune checkpoint inhibitors in esophagogastric cancer (EGC)
    Meeting Abstract

    Greally, M.; Chatila, W. K.; Margolis, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Ladanyi, M.; Kelsen, D. P.; Ilson, D. H.; Berger, M. F.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pilot study of gemcitabine, nab-paclitaxel, PEGPH20, and rivaroxaban for advanced pancreatic adenocarcinoma: An interim analysis
    Meeting Abstract

    Yu, K. H.; Mantha, S.; Tjan, C.; Kaufmann, E. S.; Brenner, R.; Lowery, M. A.; Ku, G. Y.; Raj, N. P.; Shcherba, M.; Goldberg, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 2 trial of CRS-207 and pembrolizumab in adults with recurrence of metastatic gastric, gastroesophageal junction (GEJ), or esophageal adenocarcinomas
    Meeting Abstract

    Kelly, R. J.; Abrams, T. A.; Catenacci, D. V. T.; Wainberg, Z. A.; Lin, B. S. L.; Enstrom, A.; Whiting, C. C.; Wason, P.; Murphy, A.; Brockstedt, D. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase I/II multi-center study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) for patients with locally advanced esophageal squamous cell carcinoma (ESCC)
    Meeting Abstract

    Giuroiu, I.; Ku, G. Y.; Leichman, L. P.; Du, K. L.; Oh, P.; Levinson, B. A.; Iqbal, S.; Thomas, C. R.; Wu, J. J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase Ib/II trial of durvalumab and chemoradiation (CRT) with carboplatin/paclitaxel for esophageal and gastroesophageal junction (GEJ) adenocarcinoma
    Meeting Abstract

    Greally, M.; Molena, D.; Sihag, S.; Wu, A. J. C.; Shah, P. M.; Fein, C.; Capanu, M.; Kelsen, D. P.; Janjigian, Y. Y.; Ilson, D. H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant therapy
    Book Section

    Greally, M.; Ku, G. Y.
    In Schlottmann, F.; Molena, D.; Patti, M. G. (Eds.) Esophageal Cancer: Diagnosis and Treatment (2018)

    Fulltext@MSK | Save
  • A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis
    Meeting Abstract

    Yu, K.; Mantha, S.; Tjan, C.; Kaufmann, E.; Brenner, R. B.; Lowery, M.; Ku, G.; Raj, N.; Shcherba, M.; Goldberg, Z.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression and T-cell inflamed gene expression profile (GEP) in Korean and US patients (pts) with advanced gastric cancer (GC)
    Meeting Abstract

    Rha, S. Y.; Ku, G. Y.; Kim, H. S.; Chung, H. C.; Amlashi, F. G.; Maru, D. M.; Fein, C.; Tang, L.; Savage, M. J.; Zhou, W.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitors in esophagogastric adenocarcinoma: Do the results justify the hype?
    Journal Article

    Greally, M.; Ku, G. Y.
    Journal of Thoracic Disease (2018)

    Fulltext@MSK | Save
  • Next-generation sequencing to identify predictors of survival after trimodality therapy for esophageal cancer
    Meeting Abstract

    Oh, P.; Zhang, M.; Brady, P.; Sihag, S.; Molena, D.; Ilson, D. H.; Janjigian, Y. Y.; Ku, G. Y.; Wu, A. J. C.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save